Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 136.75
-1.50 (-1.08%)
At close: Feb 13, 2026
Beijing Hotgen Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -259.33 | -191 | 28.92 | 944.74 | 2,186 | 112.07 |
Depreciation & Amortization | 89.05 | 89.05 | 70.53 | 120.29 | 68.34 | 29.15 |
Other Amortization | 15.77 | 15.77 | 7.76 | 28.15 | 5.38 | 10.94 |
Loss (Gain) From Sale of Assets | 1.63 | 1.63 | 0.64 | 0.34 | 14.21 | 0.18 |
Asset Writedown & Restructuring Costs | 55.15 | 55.15 | 36.95 | 70.06 | 8.51 | 0.14 |
Loss (Gain) From Sale of Investments | 9.36 | 9.36 | 23.68 | -10.91 | -24.88 | -8.13 |
Provision & Write-off of Bad Debts | 1.36 | 1.36 | -13.4 | 11.34 | 0.7 | 1.2 |
Other Operating Activities | 103.53 | 24.39 | -59.57 | 94.17 | 118.58 | -2.02 |
Change in Accounts Receivable | -77.16 | -77.16 | 93.75 | -22.28 | -81.52 | -19.87 |
Change in Inventory | 47.59 | 47.59 | 123.21 | 36.03 | -213.43 | -60.14 |
Change in Accounts Payable | 3.31 | 3.31 | -284.98 | -242.99 | 564.77 | 97.55 |
Change in Other Net Operating Assets | -24.34 | -24.34 | -71.27 | -32.27 | 8.46 | 4.3 |
Operating Cash Flow | -26.34 | -37.16 | -48.53 | 978.75 | 2,644 | 164.62 |
Operating Cash Flow Growth | - | - | - | -62.99% | 1506.38% | 749.79% |
Capital Expenditures | -17.29 | -51.41 | -413.37 | -565.21 | -398.86 | -172.27 |
Sale of Property, Plant & Equipment | 0.77 | 1.19 | 3.74 | 0.58 | 0.13 | 0.05 |
Divestitures | -4.89 | -7.89 | -17.11 | -0.08 | - | - |
Investment in Securities | 63.01 | 130.21 | 238.61 | -602.42 | -1,367 | - |
Other Investing Activities | 65.63 | 38.74 | 26.56 | 17.08 | 22.34 | 8.13 |
Investing Cash Flow | 107.22 | 110.83 | -161.57 | -1,130 | -1,763 | -164.1 |
Total Debt Issued | 50 | - | - | - | - | - |
Long-Term Debt Repaid | - | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 |
Total Debt Repaid | -5.12 | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 |
Net Debt Issued (Repaid) | 44.88 | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 |
Issuance of Common Stock | 2.52 | 45.02 | 3.34 | - | - | - |
Repurchase of Common Stock | -92.03 | -92.03 | -16.44 | -150.04 | - | - |
Common Dividends Paid | -0.81 | -17.34 | - | -310.98 | -93.29 | -19.1 |
Other Financing Activities | 13.66 | -10 | 3.8 | 8.32 | 9.63 | 0.69 |
Financing Cash Flow | -31.78 | -79.48 | -36.55 | -484.99 | -95.07 | -42.16 |
Foreign Exchange Rate Adjustments | -1.29 | -0.15 | -0.46 | 5.2 | -14.83 | 1.4 |
Net Cash Flow | 47.82 | -5.96 | -247.11 | -631.09 | 771.69 | -40.23 |
Free Cash Flow | -43.64 | -88.57 | -461.9 | 413.54 | 2,246 | -7.65 |
Free Cash Flow Growth | - | - | - | -81.58% | - | - |
Free Cash Flow Margin | -10.04% | -17.34% | -84.31% | 11.63% | 41.82% | -1.49% |
Free Cash Flow Per Share | -0.49 | -0.96 | -5.23 | 4.50 | 24.40 | -0.08 |
Cash Income Tax Paid | 16.94 | 8.39 | 20.06 | 371.82 | 312.86 | 0.66 |
Levered Free Cash Flow | 62.92 | 36.2 | -561.63 | 129.6 | 1,644 | -35.57 |
Unlevered Free Cash Flow | 63.21 | 36.48 | -561 | 131.05 | 1,645 | -35.29 |
Change in Working Capital | -42.87 | -42.87 | -144.05 | -279.43 | 267.89 | 21.1 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.